Crescentic Glomerulonephritis Associated with MPO-ANCA during Propylthiouracil Treatment : a Case report and Literatures Review
Main Article Content
Abstract
ANCA-related crescentic glomerulonephritis is an uncommon illness. It has become evident that ANCA, predominant of the P-ANCA type, can be detected in patients association with anti-thyroid (MPO-ANCA) during propylthiouracil (PTU) treatment. Although the serum creatinine level gradually decreased after cessation of PTU and immunosuppressive treatment, irreversible renal dysfunction persisted. Because of the widespread use of anti-thyroid medication, patients treated with PTU should be placed under vigilant observation by monitoring their urinalysis and serum creatinine level.
Article Details
![Creative Commons License](http://i.creativecommons.org/l/by-nc-nd/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Cooper DS, Drug Therapy: Anithyroid Drugs. N Engl J Med 2005; 352: 905-17.
Jennette JC, Falk RJ. Small vessei vasculitis. N Engl J Med 1997; 337: 1512-23.
Vogt BA, Youngi K, Jennette IC, Falk RJ,Burke BA. Sinaiko A. Anti-neutrophil cytoplasmic autoantibodypositive cresentic glomerulonephritis as a complication of treatment with propylthiouracil in children. Pediatr 1994; 124: 986-8.
Dolman KM, Gans ROB, Vervaat TJ, Zevenbergen G, Maingay D, Kikkels RE, etal. Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy. Lancet 1993; 342: 651-2.
Davies DJ, Moran JE, Niall JF, Ryan GB.Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovinus aetiology? Br Med 1982;285;285: 606.
Hall JB, Wadham BM, Wood CJ, Ashton V, Adam WR. Vasculitis and glomerulonephritis: a subgroup with an antineutrophil cytoplasmic antibody. Aust N J Med 1984; 14: 277-8.
Van der Woude, FJ, Rasmussen N, Lobatto S. Wiik A, Permin H, Van Es, et al. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985; 1: 425-9.
Falk RJ, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N EngI J Med 1988; 318: 1651-7.
Hoffman GS, Specks U. Antineutrophil cynoplasmic antibodies. Arthritis Rheum 1998; 41: 1521-37.
Franssen CFM, Stegeman CA, Kallenberg CGM, Gans ROB, de Jong PE, Hoomije SJ, et al. Antiproteinasc 3- and antimyeloperoxidasc-associated vasculitis. Kidney Int 2000; 57: 2195-206.
Gross WL, Schmitt WH, Csernok E. ANCA and associated diseases: immunodiagnostic and pathogenetic aspects. Clin Exp Immunol 1993; 91: 1-12.
Jennette JC, Falk RJ. Small-vessel vasculitis. N Engl J Med 1997; 337: 1512-23.
Lie JT. Aortic and extracranial large vesseI giant cell arteritis: a review of 72 cases with histopathologic documentation. Semin Arthritis Rheum 1995; 24:422-31.
Gail SK, Claire WH, Joseph G, Randi YL, Anthony SF, Menachem R, et al. Ann Intern Med 1994; 120: 919-29.
Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, et al. Wegener's granulomatosis: an analysis of 158 patients. Ann Intern Med 1992; 116: 488-98.
Hoffman GS, Specks U.Antineutrophil cytoplasmic antibodies. Arthritis Rheum 1998; 41: 1521-37.
Niles JL, Pan GL, Collins AB, Shannon T, Skates S, Fienberg R, et al. Antigen-specific radioimmunoassays for anti-neutrophil cytoplasmic antibodies in the diagnosis of rapidly progressive glomerulonephritis. I Am Soc Nephrol 1991; 2: 27-36.
Guillevin L, Cohen P, Gayraud M, Lhofe F, Jarrouse B, Casassus P. Churg-Strauss syndrome: clinical study and long-term follow-up of 96 patients. Medicine 1999; 78: 26-37.
Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP,et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthris Rheum 1990; 33: 1094-100.
Tervaert JW, Kallenberg CGM. Anti-myeloperoxidase antibodies in Churg-Strauss syndrome. J Neurol 1993; 240: 449-50.
Dillon MJ, Ansell BM. Vasculitis in children and adolescents. Rheum Dis Clin North Am 1995; 21:1115-36.
Irvine AD, Bruce IN, Walsh MY, Bingham EA. Microscopic polyangiitis: delineation of a cutaneous-limited variant associated with antimyeloperoxidase auto antibody. Arch Dermatol 1997; 133: 474-7.
Langford CA. Treatment of polyarteritis nodosa, microscopic polyangritis, and Churg-Strauss syndrome: where do we stand? Arthritis Rheum 2001; 44: 508-12.
Choi HK, Merkel PA, Walker AM, Niles JL. Drug-asso-ciated neutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyel-operoxidase antibodies. Arthritis Rheum 2000; 43:405-13.
Dolman KM, Gans ROB, Vervaat TJ, Zevenberger G,. Maingay D, Nikkels RE, et al. Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy. Lancet 1993; 342: 651-2.
Gunton JE, Stiel J, Clitton-Bligh P, Winshurst E, Mc~Elduff A. Prevalence of positive anti-neutrophil cytoplasmic antibody (ANCA) in patients receiving anti-thyroid medication. Eur J Endocrinol 2000; 142: 587.
Otsuka S, Kinebuchi A, Tabata H, Yamakage A, Yamazaki S. Myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis following propylthiouracil therapy. Br J Dermatol 2000; 142: 828-30.
Carrasco MD, Riera C, Clotet B, Grifol M, Foz M. Cutancous vasculitis associated with propylthiouracil therapy. Arch Intern Med 1987; 147: 1677.
Jiang X, Khursigara G, Rubin RI. Transformation of lupus-inducing drugs to cytotoxic products by activated neutrophils. Science 1994; 266: 810-3.
von Schmiedeberg S, Goebel C, Gleichmann E, Uetrecht J. Neutrophils and drug metabolism. Science 1995; 268: 585-6.
Lee E, Katsura H, Miki Y, Kariya K. Mechanism of inactivation of myeloperoxidase by propy///thiouracil. Biochem Pharmacol 1990; 39: 1467-71.
Yu F, Chen M, Gao Y, Wang Sx, Zou Wz. Clinical and Pathological Features of Renal Involvement in Propyithiouracil-Associated ANCA-Positive Vascutis 2007: 49: 607-14.
Faical J, Mohamed A, Richard J. Myeloperoxidase- antineutrophil cyroplasmic antibody-posive crescentic glomerulonephritis associated with benzylthiouracil therapy. Nephrol Dial Transplant 2003; 2421-3.
Jennette JC, Falk RJ. Small-Vessel Vasculis. N Engl J Med 1997; 337: 1512-23.